Related Experiment Videos
Contributing factors of pathogenesis in the Mycobacterium avium complex
1Department of Microbiology and Immunology, Texas College of Osteopathic Medicine, Fort Worth 76107.
Research in Microbiology
|May 1, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1.
Antimicrobial agents and chemotherapy·2010
New antifolate inhibitors for Mycobacterium avium.
Medicinal chemistry (Shariqah (United Arab Emirates))·2006
New Mycobacterium avium antifolate shows synergistic effect when used in combination with dihydropteroate synthase inhibitors.
Antimicrobial agents and chemotherapy·2005
Treatment of tuberculosis using a combination of sustained-release rifampin-loaded microspheres and oral dosing with isoniazid.
Antimicrobial agents and chemotherapy·2001
Treatment of mycobacterial infections.
Revue scientifique et technique (International Office of Epizootics)·2001
Antimycobacterial activities of 2,4-diamino-5-deazapteridine derivatives and effects on mycobacterial dihydrofolate reductase.
Antimicrobial agents and chemotherapy·2000
Co-expression network insights into Leptospira interrogans pathogenesis.
Research in microbiology·2025
Differential DNA methylation associated with virulence attenuation in Edwardsiella piscicida.
Research in microbiology·2025
[Corrigendum] EBM84 attenuates airway inflammation and mucus hypersecretion in an ovalbumin‑induced murine model of asthma.
International journal of molecular medicine·2026
Lungs and Beyond: Seizures as Presenting Symptom in a Patient With Mycobacterium chimaera Infection.
Journal of community hospital internal medicine perspectives·2026